Eversept Partners, LP Argenx Se Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$356.01 - $451.55 $7.09 Million - $9 Million
-19,925 Reduced 36.55%
34,593 $14.9 Million
Q1 2024

May 15, 2024
SELL
$356.95 - $413.29 $11.2 Million - $12.9 Million
-31,314 Reduced 36.48%
54,518 $21.5 Million
Q4 2023

Feb 14, 2024
BUY
$338.91 - $506.01 $27.5 Million - $41.1 Million
81,267 Added 1780.22%
85,832 $32.7 Million
Q3 2023

Nov 14, 2023
BUY
$369.35 - $548.43 $151,802 - $225,404
411 Added 9.89%
4,565 $2.24 Million
Q2 2023

Nov 08, 2023
BUY
$360.14 - $422.58 $114,524 - $134,380
318 Added 8.29%
4,154 $1.62 Million
Q2 2023

Aug 14, 2023
BUY
$360.14 - $422.58 $114,524 - $134,380
318 Added 8.29%
4,154 $1.62 Million
Q1 2023

Nov 08, 2023
BUY
$334.23 - $403.65 $120,322 - $145,314
360 Added 10.36%
3,836 $1.43 Million
Q1 2023

May 15, 2023
BUY
$334.23 - $403.65 $120,322 - $145,314
360 Added 10.36%
3,836 $1.43 Million
Q4 2022

Nov 08, 2023
SELL
$342.17 - $402.31 $8,896 - $10,460
-26 Reduced 0.74%
3,476 $1.32 Million
Q4 2022

Feb 14, 2023
SELL
$342.17 - $402.31 $8,896 - $10,460
-26 Reduced 0.74%
3,476 $1.32 Million
Q3 2022

Nov 08, 2023
SELL
$343.2 - $395.75 $15.7 Million - $18.1 Million
-45,634 Reduced 92.87%
3,502 $1.24 Million
Q3 2022

Nov 14, 2022
SELL
$343.2 - $395.75 $15.7 Million - $18.1 Million
-45,634 Reduced 92.87%
3,502 $1.24 Million
Q2 2022

Nov 08, 2023
BUY
$269.58 - $378.88 $7.01 Million - $9.85 Million
25,994 Added 112.32%
49,136 $18.6 Million
Q2 2022

Aug 15, 2022
BUY
$269.58 - $378.88 $7.01 Million - $9.85 Million
25,994 Added 112.32%
49,136 $18.6 Million
Q1 2022

Nov 08, 2023
BUY
$254.45 - $351.06 $4.83 Million - $6.67 Million
18,988 Added 457.1%
23,142 $7.3 Million
Q1 2022

May 16, 2022
BUY
$254.45 - $351.06 $418,824 - $577,844
1,646 Added 7.66%
23,142 $7.3 Million
Q4 2021

Nov 08, 2023
BUY
$272.01 - $353.03 $4.28 Million - $5.56 Million
15,750 Added 274.1%
21,496 $7.53 Million
Q4 2021

Feb 14, 2022
BUY
$272.01 - $353.03 $4.28 Million - $5.56 Million
15,750 Added 274.1%
21,496 $7.53 Million
Q3 2021

Nov 08, 2023
SELL
$295.0 - $350.58 $8.89 Million - $10.6 Million
-30,140 Reduced 83.99%
5,746 $1.74 Million
Q3 2021

Nov 15, 2021
BUY
$295.0 - $350.58 $1.7 Million - $2.01 Million
5,746 New
5,746 $1.74 Million
Q2 2021

Aug 16, 2021
SELL
$257.11 - $319.92 $9.23 Million - $11.5 Million
-35,886 Closed
0 $0
Q1 2021

Nov 08, 2023
BUY
$268.3 - $380.31 $8.51 Million - $12.1 Million
31,732 Added 763.89%
35,886 $9.88 Million
Q1 2021

May 13, 2021
BUY
$268.3 - $380.31 $9.63 Million - $13.6 Million
35,886 New
35,886 $9.88 Million
Q1 2020

May 13, 2020
SELL
$108.83 - $165.23 $4.05 Million - $6.15 Million
-37,204 Closed
0 $0
Q4 2019

Nov 08, 2023
BUY
$106.59 - $164.21 $127,908 - $197,052
1,200 Added 3.33%
37,204 $5.97 Million
Q4 2019

Feb 13, 2020
BUY
$106.59 - $164.21 $127,908 - $197,052
1,200 Added 3.33%
37,204 $5.97 Million
Q3 2019

Nov 08, 2023
SELL
$113.31 - $150.51 $1.39 Million - $1.85 Million
-12,260 Reduced 25.4%
36,004 $4.1 Million
Q3 2019

Nov 13, 2019
SELL
$113.31 - $150.51 $1.39 Million - $1.85 Million
-12,260 Reduced 25.4%
36,004 $4.1 Million
Q2 2019

Nov 08, 2023
BUY
$115.0 - $141.58 $1.03 Million - $1.26 Million
8,930 Added 22.7%
48,264 $6.83 Million
Q2 2019

Aug 13, 2019
BUY
$115.0 - $141.58 $1.03 Million - $1.26 Million
8,930 Added 22.7%
48,264 $6.83 Million
Q1 2019

Nov 08, 2023
BUY
$98.85 - $134.59 $109,723 - $149,394
1,110 Added 2.9%
39,334 $4.91 Million
Q1 2019

May 14, 2019
BUY
$98.85 - $134.59 $109,723 - $149,394
1,110 Added 2.9%
39,334 $4.91 Million
Q4 2018

Nov 08, 2023
BUY
$63.81 - $109.82 $936,092 - $1.61 Million
14,670 Added 62.28%
38,224 $3.67 Million
Q4 2018

Feb 13, 2019
BUY
$63.81 - $109.82 $936,092 - $1.61 Million
14,670 Added 62.28%
38,224 $3.67 Million
Q3 2018

Nov 08, 2023
SELL
$75.5 - $96.63 $62,665 - $80,202
-830 Reduced 3.4%
23,554 $1.79 Million
Q3 2018

Nov 14, 2018
SELL
$75.5 - $96.63 $62,665 - $80,202
-830 Reduced 3.4%
23,554 $1.79 Million
Q2 2018

Nov 08, 2023
SELL
$74.84 - $100.16 $853,176 - $1.14 Million
-11,400 Reduced 31.86%
24,384 $2.02 Million
Q2 2018

Aug 14, 2018
SELL
$74.84 - $100.16 $853,176 - $1.14 Million
-11,400 Reduced 31.86%
24,384 $2.02 Million
Q1 2018

Nov 08, 2023
BUY
$56.95 - $85.19 $1.8 Million - $2.69 Million
31,630 Added 761.43%
35,784 $2.88 Billion
Q1 2018

May 14, 2018
BUY
$56.95 - $85.19 $462,661 - $692,083
8,124 Added 29.37%
35,784 $2.88 Million
Q4 2017

Nov 08, 2023
BUY
$22.57 - $63.56 $530,530 - $1.49 Million
23,506 Added 565.86%
27,660 $1.75 Billion
Q4 2017

Feb 12, 2018
BUY
$22.57 - $63.56 $624,286 - $1.76 Million
27,660
27,660 $1.75 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email